UROGEN PHARMA LTD COM is a security (CUSIP M96088105) tracked across SEC portfolio filings. 173 institutional managers reported $825.9M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $6.8M via N-PORT as of 2026-05-31.
Showing 15 of 173 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| RTW INVESTMENTS, LP | NEW YORK, NY | $81.7M | 4,543,895 |
| BlackRock, Inc. | New York, NY | $51.2M | 2,845,567 |
| TORONTO DOMINION BANK | Toronto, Ontario, A6 | $47.0M | 2,616,714 |
| MORGAN STANLEY | NEW YORK, NY | $46.0M | 2,560,038 |
| Kynam Capital Management, LP | PRINCETON, NJ | $40.4M | 2,247,393 |
| Jefferies Financial Group Inc. | NEW YORK, NY | $39.5M | 2,199,652 |
| Paradigm Biocapital Advisors LP | NEW YORK, NY | $30.6M | 1,703,949 |
| ACORN CAPITAL ADVISORS, LLC | NEW YORK, NY | $30.1M | 1,673,420 |
| AMERICAN CENTURY COMPANIES INC | KANSAS CITY, MO | $29.4M | 1,637,570 |
| SILVERARC CAPITAL MANAGEMENT, LLC | BOSTON, MA | $27.0M | 1,503,045 |
| Opaleye Management Inc. | Boston, MA | $25.7M | 1,430,000 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | Boston, MA | $23.6M | 1,314,112 |
| MENORA MIVTACHIM HOLDINGS LTD. | Ramat Gan, L3 | $20.7M | 1,152,531 |
| D. E. Shaw & Co., Inc. | New York, NY | $18.4M | 1,023,159 |
| J. Goldman & Co LP | NEW YORK, NY | $17.8M | 938,870 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $5.8M | 3.32% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $931K | 5.07% |
| Strategic Allocation: Aggressive Fund | American Century Strategic Asset Allocations Inc | $39K | 0.53% |
| TIAA Separate Account VA-1 - Stock Index Account | TIAA Separate Account VA-1 | $9K | 0.07% |